Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New CBER Panel Should Be Established For Combo Products Review – AAOS

This article was originally published in The Gray Sheet

Executive Summary

A new FDA advisory panel under the purview of the Center for Biologics Evaluation & Research should be created specifically to review combination products, the American Academy of Orthopaedic Surgeons recommends

You may also be interested in...

FDA Will Accept Primary Mode Of Action Definition Comments Until Jan. 24

Clarification of primary mode of action (PMOA) is a priority for the soon-to-be established Office of Combination Products, according to Mark Kramer, director of the agency's current combination product program within the FDA Office of the Ombudsman

Wyeth BMP-2 Should Be Limited To “Problem” Fractures – Panel

Wyeth's InductOs recombinant human bone morphogenic protein-2 indications for use should be limited to "problem" fractures, according to FDA's Orthopaedic and Rehabilitation Devices Panel

Medical Imaging Drugs Advisory Committee Will Phase Out By March 2004

FDA's Medical Imaging Drugs and Pharmacy Compounding advisory committees will terminate after their charters expire in February 2004

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts